chr5-174724754-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002449.5(MSX2):c.95A>T(p.Glu32Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000274 in 1,569,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002449.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSX2 | NM_002449.5 | c.95A>T | p.Glu32Val | missense_variant | 1/2 | ENST00000239243.7 | |
MSX2 | NM_001363626.2 | c.95A>T | p.Glu32Val | missense_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSX2 | ENST00000239243.7 | c.95A>T | p.Glu32Val | missense_variant | 1/2 | 1 | NM_002449.5 | P1 | |
MSX2 | ENST00000507785.2 | c.95A>T | p.Glu32Val | missense_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000238 AC: 4AN: 167862Hom.: 0 AF XY: 0.0000218 AC XY: 2AN XY: 91562
GnomAD4 exome AF: 0.0000247 AC: 35AN: 1417040Hom.: 0 Cov.: 36 AF XY: 0.0000300 AC XY: 21AN XY: 700780
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74266
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.95A>T (p.E32V) alteration is located in exon 1 (coding exon 1) of the MSX2 gene. This alteration results from a A to T substitution at nucleotide position 95, causing the glutamic acid (E) at amino acid position 32 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Cranium bifidum occultum Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 32 of the MSX2 protein (p.Glu32Val). This variant is present in population databases (rs780593593, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MSX2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1468184). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at